Assuras

Changes in the Management Board and the Board of Directors of Cembra

Retrieved on: 
Wednesday, April 10, 2024
CIO, Mastercard, Annual, Urner Kantonalbank, Small Business Saturday, Assuras, Avaloq, Bank, IAIS, Operational excellence, Ergo, Schmitt, Accenture, Fraunhofer Society, Artificial intelligence, Delivery, Management

Zurich, 15 March 2024 – Sandra Babylon and Christian Stolz enhance the Management Board of Cembra.

Key Points: 
  • Zurich, 15 March 2024 – Sandra Babylon and Christian Stolz enhance the Management Board of Cembra.
  • Sandra Hauser will be proposed for election to the Board of Directors at the Annual General Meeting.
  • He has been part of the Bank's management team since the takeover by Cembra in autumn 2022.
  • Alongside him, Sandra Babylon will join the Management Board of Cembra from 1 June 2024.

ABARCA RECEIVES PBMI EXCELLENCE AWARD FOR COST CONTAINMENT STRATEGIES

Retrieved on: 
Thursday, September 15, 2022
PBM, Organization, Population, Industry, Decision-making, CEO, Technology, Solution, Research, Multimedia, Education, Healthcare, Management, Health insurance, Pharmaceutical industry, Assuras

AVENTURA, Fla., Sept. 15, 2022 /PRNewswire/ -- Abarca, a pharmacy benefit manager (PBM) that is transforming the industry with a new approach to drug trend management and business practices, has been awarded the 2022 PBMI Excellence Award for Assura, the company's innovative financial solution, from the Pharmacy Benefit Management Institute.

Key Points: 
  • Through Assura, Abarca guarantees the net cost of drugs, including specialty medications, by offering a fixed, per-script cost for a plan's entire population.
  • "We applaud Abarca's innovation in cost containment and the introduction of Assura," said Brian Haug ,executive director of the Pharmacy Benefit Management Institute.
  • Since 2016, the PBMI Excellence Awards have recognized organizations for groundbreaking strategies addressing several challenges within the healthcare industry.
  • The winning organizations are being recognized for developing best-in-class strategies to address the challenges of drug cost management, quality improvement, and care management strategies.

Assuras Partners With Non-Profit A Voice from Prison For Prisoners' Educational Purposes

Retrieved on: 
Wednesday, July 27, 2022
Recidivism, Certification, Education, Project management, Solution, Partnership, Growth, Technology, Mark (given name), Learning, Human voice, Lean Six Sigma, Drug, Medicine, Assuras

Dallas, Texas--(Newsfile Corp. - July 26, 2022) - Assuras is an emerging management consulting firm that provides business and technology solutions which has recently partnered with the non-profit A Voice From Prison for prisoners educational purposes.

Key Points: 
  • Dallas, Texas--(Newsfile Corp. - July 26, 2022) - Assuras is an emerging management consulting firm that provides business and technology solutions which has recently partnered with the non-profit A Voice From Prison for prisoners educational purposes.
  • The company is globally known as a management consulting firm, business practice efficiency leader, and technology solutions provider.
  • "A Voice From Prison" is a non-profit organization that advocates for criminal justice reform and constitutional rights, providing education and training for recently released prisoners returning to society.
  • To apply, a prisoner must reach out to A Voice From Prison via their website, which is doing the enrollments following verification of their incarceration.

Independent Methodology Review Affirms Abarca Solution is Transparent and Predictable

Retrieved on: 
Wednesday, April 20, 2022
CEO, PBM, Review, Technology, Mouth, City, Multimedia, Industry, Milliman, Population, Elijah Cummings Lower Drug Costs Now Act, Pharmaceutical industry, Health insurance, Risk management, Assuras

AVENTURA, Fla., April 20, 2022 /PRNewswire/ -- Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices, has released the findings of an independent report about their drug cost guarantee solution, Assura. The review, conducted by the respected global healthcare consulting firm Milliman, found Abarca's approach to be actuarially appropriate.

Key Points: 
  • The review, conducted by the respected global healthcare consulting firm Milliman , found Abarca's approach to be actuarially appropriate.
  • "This is the first solution of its kind PBMs typically don't take on the financial risk of higher drug costs," said Jason Borschow, Abarca's President & CEO .
  • To evaluate this approach, Milliman conducted a thorough independent methodology review of Abarca's reconciliation process to ensure that all calculations and methodologies used to deliver the net-cost guarantee were appropriate.
  • "We agree that it is an appropriate methodology and that the calculations we reviewed from Abarca follow the prescribed methodology and are actuarially appropriate," the report stated.